Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
7.35
+0.42 (6.06%)
Nov 21, 2024, 1:09 PM EST - Market open
Silence Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 344 | 672 | 547 | 715 | 611 | - | |
Market Cap Growth | 135.77% | 22.71% | -23.44% | 17.04% | - | - | |
Enterprise Value | 152 | 600 | 448 | 612 | 549 | - | |
Last Close Price | 6.93 | 17.37 | 15.25 | 23.89 | 22.00 | - | |
PS Ratio | 14.06 | 20.78 | 25.96 | 42.53 | 81.67 | - | |
PB Ratio | 2.58 | 30.93 | 20.58 | 61.93 | 49.39 | - | |
P/TBV Ratio | 7.32 | 59.08 | 33.06 | 580.25 | 487.96 | - | |
P/FCF Ratio | - | - | - | 96.09 | - | - | |
P/OCF Ratio | - | - | - | 77.58 | - | - | |
EV/Sales Ratio | 6.96 | 18.57 | 21.23 | 36.40 | 73.34 | - | |
EV/FCF Ratio | - | - | - | 82.24 | - | - | |
Debt / Equity Ratio | 0.00 | 0.02 | 0.02 | 0.02 | 0.04 | 0.01 | |
Debt / FCF Ratio | - | - | - | 0.02 | - | 0.17 | |
Asset Turnover | 0.12 | 0.25 | 0.17 | 0.14 | 0.08 | 0.01 | |
Quick Ratio | 8.61 | 4.10 | 4.03 | 5.41 | 2.77 | 3.84 | |
Current Ratio | 9.31 | 4.56 | 4.41 | 5.69 | 2.99 | 3.88 | |
Return on Equity (ROE) | -102.80% | -221.19% | -264.65% | -448.22% | -217.21% | -69.98% | |
Return on Assets (ROA) | -27.27% | -30.80% | -29.82% | -31.44% | -29.33% | -33.45% | |
Return on Capital (ROIC) | -63.40% | -155.63% | -194.80% | -317.04% | -126.58% | -50.52% | |
Earnings Yield | -25.05% | -8.20% | -8.91% | -7.46% | -7.27% | - | |
FCF Yield | -7.47% | -10.04% | 1.04% | -2.52% | - | |
Buyback Yield / Dilution | -21.50% | -15.21% | -8.58% | -8.78% | -8.85% | -6.85% | |
Total Shareholder Return | -21.50% | -15.21% | -8.58% | -8.78% | -8.85% | -6.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.